Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma.
Department of Oncology, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia Hospital, via del Pozzo 71, 41124 Modena, Italy.
Michela
M
Maur
Chiara
C
Tomasello
Antonio
A
Frassoldati
Maria Vittoria
MV
Dieci
Elena
E
Barbieri
Pierfranco
P
Conte
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D012878:Skin Neoplasms / Q000188:drug therapy*; D014625:Vaginal Neoplasms / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab